Confirma Inc. this week unveiled three promotions

TriMed Staff | | Health Imaging | Artificial Intelligence
Dan Bickford has been elevated to vice president of sales and marketing. Prior to Confirma, Bickford served in senior sales and marketing positions with NexCura Inc., ESC Medical Systems and Neopath (now Tripath).

 Chris Wood has become vice president of research and development. Wood previously held various senior management positions with the former Picker International Inc. and Siemens Medical Solutions USA Inc. He has been involved with product development for the post-processing of medical images in CT, nuclear medicine, ultrasound and magnetic resonance imaging.

 Mary Gatewood has been promoted to director of marketing. Gatewood previously held marketing positions at the former Pointshare (now Siemens Medical Solutions) and Ostex International.

TriMed Staff

Related Content

Experts highlight 'significant concerns' with fluctuating accuracy of popular large language models
FDA clears AI screening tool for cardiac amyloidosis
Are providers too trusting of AI's advice?
Pairing an alert system with CAD software halves time-to-treatment for pneumothorax
Deep learning reconstruction cuts radiation and contrast dose by half in aortic CTA exams
New study highlights the need to include more challenging datasets in AI training

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.